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Methods:  Participants  with  a  diagnosis  of  post-infectious  bronchiolitis  obliterans,  who  were
being followed-up  at  two  specialized  outpatient  clinics  of  Pediatric  Pulmonology  in  Porto
Alegre, Brazil,  and  controls  aged  between  8  and  17  years,  of  both  genders,  were  included
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n patients with bronchiolitis obliterans. J Pediatr (Rio J). 2018;94:374--9.
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in  the  study.  Controls  were  paired  by  gender,  age,  and  socioeconomic  level  in  relation  to  the
group of  participants  with  post-infectious  bronchiolitis  obliterans.  The  version  of  the  Pediatric
Quality of  Life  Inventory  (PedsQ)  tool  validated  for  Brazil  was  applied  for  the  assessment  of
Health-related  Quality  of  Life,  through  an  interview.  The  comparison  of  the  Health-related
Quality of  Life  means  between  the  groups  was  performed  using  Student’s  t-test  for  independent
samples and  the  chi-squared  test,  for  categorical  variables.
Results:  34  patients  diagnosed  with  post-infectious  bronchiolitis  obliterans  and  34  controls  par-
ticipated in  the  study.  The  mean  age  of  the  children  included  in  the  study  was  11.2  ±  2.5
years, and  49  (72%)  of  them  were  males.  The  groups  showed  no  significant  differences  in
relation to  these  variables.  The  quality  of  life  score  was  significantly  and  clinically  lower
in the  post-infectious  bronchiolitis  obliterans  group  when  compared  with  controls  in  the
health (72.36  ±  15.6,  81.06  ±  16.4,  p  =  0.031)  and  school  domains  (62.34  ±  20.7,  72.94  ±  21.3,
p =  0.043),  as  well  as  in  the  total  score  (69.53  ±  14.9,  78.02  ±  14.8,  p  =  0.024),  respectively.
Conclusion:  Patients  with  post-infectious  bronchiolitis  obliterans  presented  lower  health-
related quality  of  life  scores  when  compared  with  healthy  individuals  in  the  total  score  and
in the  health  and  school  domains.
© 2017  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  This  is  an  open
access article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
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Qualidade  de  vida  relacionada  à  saúde  em  pacientes  com  bronquiolite  obliterante
Resumo
Objetivo:  Avaliar  a  qualidade  de  vida  relacionada  à  saúde  geral  em  participantes  com  bron-
quiolite obliterante.
Métodos:  Foram  incluídos  no  estudo  participantes  com  diagnóstico  de  bronquiolite  obliterante
pós-infecciosa  que  estavam  em  acompanhamento  em  dois  ambulatórios  especializados  de  pneu-
mologia pediátrica  em  Porto  Alegre,  Brasil  e  controles,  com  idades  entre  8  e  17  anos,  de  ambos
os sexos.  Os  controles  foram  pareados  por  sexo,  idade  e  nível  socioeconômico  em  relação  ao
grupo de  participantes  com  bronquiolite  obliterante  pós-infecciosa.  Para  avaliação  da  Qualidade
de Vida  Relacionada  à  Saúde  geral  foi  aplicado  a  versão  validada  para  o  Brasil  do  instrumento
PedsQL (Pediatric  Quality  of  Life  Inventory),  por  meio  de  entrevista.  A  comparação  entre  as
médias da  Qualidade  de  Vida  Relacionada  à  Saúde  entre  os  grupos  foi  realizada  mediante  o
teste t  para  amostras  independentes  e  para  as  variáveis  categóricas  por  teste  Qui-quadrado.
Resultados:  Participaram  do  estudo  34  pacientes  com  diagnóstico  de  bronquiolite  obliterante
pós-infecciosa  e  34  controles.  A  média  da  idade  das  crianças  incluídas  foi  11,2  ±  2,5  anos  e  49
(72%) deles  eram  do  sexo  masculino.  Os  grupos  não  apresentaram  diferenças  significativas  em
relação a  essas  variáveis.  O  escore  de  qualidade  de  vida  foi  significativamente  e  clinicamente
menor no  grupo  bronquiolite  obliterante  pós-infecciosa  em  comparação  com  o  controle  nos
domínios saúde:  (72,36  ±  15,6;  81,06  ±  16,4;  p  =  0,031);  escolar:  (62,34  ±  20,7;  72,94  ±  21,3;
p =  0,043)  e  no  escore  total  (69,53  ±  14,9;  78,02  ±  14,8,  p  =  0,024),  respectivamente.
Conclusão:  Concluímos  que  os  pacientes  com  bronquiolite  obliterante  pós-infecciosa  apresen-
tam escores  de  qualidade  de  vida  relacionados  à  saúde  menor  que  indivíduos  saudáveis  no
escore total  e  nos  domínios  saúde  e  escolares.
© 2017  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  Este é  um  artigo








Post-infectious  bronchiolitis  obliterans  (PIBO)  is  a  chronic
obstructive  pulmonary  disease  that  is  uncommon  in  child-
hood,  but  leads  to  a  significant  impairment  of  lung  function
at  rest.1,2 Recently,  two  studies  also  demonstrated  a
decrease  in  cardiometabolic  capacity  during  maximal  exer-
cise  test  in  children  with  PIBO,3,4 which  may  indicate
impairment  in  daily  life  activities  and  in  subjective  out-





Currently,  the  use  of  tools  that  evaluate  the  individual’s
ifferent  domains  has  been  promoted  in  clinical  practice,
ince  these  tools  allow  the  evaluation  of  the  disease  impact
hrough  a  subjective  view  of  the  patient.6,7 Studies  indi-
ate  that  structured  questionnaires  answered  by  the  patient
an  capture  the  individual’s  perspective  in  a  more  neu-
ral  manner,  despite  the  interpretation  bias.  Moreover,  the
se  of  a  subjective  and  multidimensional  tool  in  clinical
ractice  allows  the  consideration  that  changes  in  health

































































































ogical,  and  social  aspects  of  the  patient’s  life,  and  vice
ersa.  Factors  that  are  specific  to  the  individuals  and  that
nteract  with  them  can  modify  the  health  status.  Among
hese,  the  health-related  quality  of  life  (HRQoL)  assessment
as  been  recognized  as  an  important  method  for  evaluating
atients’  physical  and  psychosocial  health.6 Studies  inves-
igating  HRQoL  in  children  with  asthma,  otitis,  and  cystic
brosis  suggested  that  children  with  chronic  diseases  have
ower  HRQoL  scores  than  healthy  controls,  and  that  specific
nterventions  can  improve  this  outcome.8
A  significant  number  of  guidelines  for  patients  with
hronic  pulmonary  disease  recommend  the  use  of  tools  that
ssess  HRQoL  in  clinical  practice.9 HRQoL  assessment  has
lso  been  highly  appreciated  as  a  clinical  outcome  in  studies
hat  evaluate  the  effectiveness  of  interventions;  from  health
lanning  to  studies  that  monitor  the  health  of  populations.
Although  in  recent  years  there  has  been  an  improve-
ent  in  the  diagnostic  and  therapeutic  techniques  of  PIBO
atients,  more  multidimensional  and  subjective  methods
hat  can  describe  the  consequences  of  the  disease  and  the
reatment  in  the  different  domains  considered  are  still  nec-
ssary.  Based  on  this  perspective,  the  present  study  aimed
o  evaluate  the  HRQoL  of  patients  with  a  diagnosis  of  PIBO.
ethods
he  writing  of  the  article  followed  the  STROBE  guidelines.10
tudy  design
his  was  a  cross-sectional  study.
ontext
he  research  is  part  of  an  umbrella  project  entitled
‘Cardiorespiratory  Evaluation  of  Children  with  Post-Viral
ronchiolitis  Obliterans.’’  The  patients  included  in  the
resent  study  were  periodically  followed-up  at  pediatric
ulmonology  outpatient  clinics  of  the  Brazilian  Unified
ealth  System  (Sistema  Único  de  Saúde  [SUS]),  referral  ser-
ices  for  the  treatment  of  this  disease  in  the  city  of  Porto
legre,  state  of  Rio  Grande  do  Sul,  Brazil.  The  sample  was
ecruited  in  the  outpatient  clinics,  whereas  the  question-
aires  and  pulmonary  function  tests  were  performed  in  a




he  study  included  a  convenience  sample  of  children  and
dolescents  with  a  previous  diagnosis  of  PIBO  aged  8--16
ears.
The  diagnosis  was  based  on  the  association  of  previ-
usly  defined  clinical,  radiological,  and  functional  criteria11:
 --  history  of  acute  pulmonary  infection  in  a  previously
ealthy  child  younger  than  2  years;  2  --  persistent  respi-
atory  signs  and  symptoms  four  weeks  after  the  initial
vent;  3  --  high-resolution  computed  tomography  showing
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s  mosaic  pattern,  bronchiectasis,  or  atelectasis;  4  --  air-
ow  limitation  by  pulmonary  function  tests;  5  --  exclusion
f  other  chronic  lung  diseases  that  occur  with  persistent
espiratory  symptoms  such  as:  severe  asthma,  cystic  fibro-
is,  alpha-1-antitrypsin  deficiency,  and  immunodeficiencies,
mong  others.
Children  with  other  chronic  conditions  that  could
ompromise  their  quality  of  life  were  excluded.  Healthy
hildren  were  thus  classified  as  they  did  not  have  any
hronic  diseases  and  did  not  use  medication  continuously.
he  children  were  selected  in  a  public  school  due  to  social
lass  similarities.  The  individuals  in  the  control  group  were
ender-  and  age-matched  with  the  patient  group.
utcome  variable
he  present  study  adopted  HRQoL  as  the  outcome  variable.
ata  source  and  measurements
ll  evaluations  of  the  present  study,  pulmonary  function
ests,  and  questionnaires  were  carried  out  at  Hospital  de
línicas  de  Porto  Alegre  (HCPA).
ulmonary  function  test
he  technical  procedures  and  the  acceptability  and  repro-
ucibility  criteria  for  the  performance  of  pulmonary
unction  tests  followed  the  guidelines  of  the  American  Tho-
acic  Society.3 Spirometry  was  performed  in  a  Master-Screen
aeger  equipment  (CareFusion,  Germany)  and  the  following
arameters  were  evaluated:  forced  vital  capacity;  %FVC;
orced  expiratory  volume  in  the  first  second,  %FEV1;  ratio
etween  FEV1 and  FVC,  FEV1/FVC;  forced  expiratory  flow
etween  25%  and  75%  of  FVC;  and  FEF25--75%.
Data  are  shown  as  a  percentage  of  the  predicted  value
ased  on  the  Knudson  reference  values10 for  spirometry.  All
xaminations  were  performed  by  the  same  technician  and
n  the  morning.
ealth-related  Quality  of  Life  (HRQoL)
he  generic  questionnaire  PedsQLTM 4.0,  validated  in  Brazil,
as  applied  to  assess  HRQoL.12,13 The  tool  includes  23  items
hat  comprise  the  following  domains:  1  --  physical  domain
eight  items);  2  --  emotional  domain,  (five  items);  3  --  social
omain  (five  items);  and  4  --  school  domain  (five  items).  The
edsQLTM 4.0  generic  questionnaire  consists  of  parallel  self-
ssessment  forms  for  children.
The  evaluation  of  the  children  used  in  the  present
esearch  includes  the  age  groups  of  8--12  and  13--18  years.
he  items  refer  to  the  evaluation  of  the  previous  month,  and
he  child/adolescent  respondents  use  a  five-level  response
cale,  in  which  0  = never  a  problem;  1  =  almost  never  a  prob-
em;  2  =  sometimes  it  is  a  problem;  3  =  is  often  a  problem;
nd  4  = almost  always  a  problem.  The  PedsQLTM was  applied
y  the  interviewer  to  children  and  adolescents.  The  items
ere  inversely  scored  and  linearly  transposed  into  a  0--100
cale,  in  which  0  =  100,  1  =  75,  2  =  50,  3  =  25,  4  =  0;  thus,  the
igher  the  score,  the  better  the  HRQoL.
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Table  1  Sample  characteristics.
PIBO  (n  =  34)  Control  (n  =  34)  p
Gender,
(male),  n  (%)
27  (79.4)  22  (64.7)  0.280a
Age  (years),
mean  ±  SD
11.82  ±  2.61 11.82  ±  2.56 1.000b
Age  range  (≥12
years),  n  (%)
19  (55.9)  20  (58.8)  0.500a
FVC  (%),
mean  ±  SD
88.97  ±  19.64  --
FEV1 (%),
mean  ±  SD
77.21  ±  22.50  --
FEF25--75% (%),
mean  ±  SD
72.79  ±  22.79 --
FEV1/FVC,
mean  ±  SD
0.62  ±  0.12  --
PIBO, post-infectious bronchiolitis obliterans; SD, standard
deviation; FVC, percentage of the predicted for forced vital
capacity; FEV1, percentage of the predicted for forced expi-
ratory volume in the first second; FEF25--75%, percentage of the
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Bias
To  avoid  possible  measurement  biases,  all  measurements
were  performed  by  the  same  evaluator,  following  the
established  standards  for  performing  the  examinations  and
applying  the  questionnaires.  The  children  answered  the
questionnaire  before  the  medical  appointment,  in  the  pres-
ence  of  the  interviewer  only.
Sample  size
Starting  from  a  significant  minimum  difference  of  four  points
between  the  groups  in  the  questionnaire,  a  standard  devi-
ation  of  4,  considering  an  alpha  value  of  5%  and  a  beta  of
20%,  the  minimum  number  of  participants  in  each  group  was
defined  as  22.
Statistical  analysis
The  distribution  of  variables  was  assessed  using  the
Kolmogorov--Smirnov  test.  Continuous  variables  were  shown
as  means  and  standard  deviations,  whereas  the  categorical
variables  were  shown  as  absolute  and  relative  frequencies.
The  comparison  between  the  measures  of  quality  of  life  and
age  was  performed  using  Student’s  t-test  for  independent
samples  and  the  chi-squared  test  for  the  gender  variable.
The  minimum  significant  difference  considered  in  the  Ped-
sQL  life  questionnaire  is  4  points.  The  level  of  significance
was  set  at  5%.  Data  analysis  was  performed  using  SPSS  (SPSS
Statistics  for  Windows,  Version  17.0,  Chicago,  USA).
Ethical  aspects
The  use  of  the  research  tool  was  previously  authorized  by
the  author  of  the  PedsQL  questionnaire.  The  project  was
approved  by  the  Research  Ethics  Committee  (REC)  of  the
HCPA,  in  accordance  with  the  current  international  and
national  standards  and  guidelines  under  No.  09-492.  The  par-
ticipants’  parents  or  guardians  signed  the  informed  consent
form  and  the  children  also  expressed  their  willingness  to
participate  in  the  research  as  suggested  by  the  REC.
Results
A  total  of  34  patients  diagnosed  with  PIBO  and  34  controls
participated  in  the  study.  The  mean  age  of  the  children
included  in  the  study  was  11.2  ±  2.5  years;  39  (57.3%)  were
schoolchildren  aged  >12  years  and  49  (72%)  of  them  were
males.  The  groups  did  not  show  any  significant  differences
in  relation  to  these  variables.  Regarding  pulmonary  func-
tion,  PIBO  patients  had  a  mean  percentage  of  the  predicted
value  for  forced  vital  capacity,  forced  expiratory  volume  in
the  first  second,  mean  forced  expiratory  flow,  and  FEV1/FVC
of  88.97%,  77.21%  72.79%  and  0.62,  respectively,  demon-
strating  pulmonary  involvement  (Table  1).  The  mean  level
of  schooling  of  the  parents  of  children  with  PIBO  was  6.2
years.
The  quality  of  life  score  was  significantly  and  clini-
cally  lower  in  the  PIBO  group  compared  to  the  control





a Student’s t-test for independent samples.
b Chi-squared test.
ively;  p  =  0.031)  and  school  domains:  (62.34  ±  20.7  vs.
2.94  ±  21.3,  respectively;  p  =  0.043)  and  in  the  total
core  (69.53  ±  14.9  vs.  78.02  ±  14.8,  respectively;  p  =  0.024;
able  2).
iscussion
he  present  study  demonstrated  that  patients  with  PIBO
resent  lower  HRQoL  scores  than  healthy  individuals,  in  the
otal  score  and  in  the  health  and  school  domains.
There  is  a  scarcity  of  studies  investigating  quality  of
ife  impairment  in  PIBO  patients.  However,  studies  with
ther  chronic  obstructive  pulmonary  diseases,  such  as  cys-
ic  fibrosis  and  asthma,  have  already  demonstrated  the
RQoL  impairment  in  children.14 A  recent  meta-analysis15
ssessed  the  quality  of  life  of  pediatric  patients  with  asthma
ompared  with  healthy  controls,  using  15  studies  published
etween  1994  and  2013.
The  study  identified  a  decrease  in  the  quality  of  life
cores  in  children  with  asthma  when  compared  to  controls;
he  patients’  mean  values  were  comparable  to  the  present
esults  in  patients  with  PIBO.15 The  similarity  of  HRQoL
cores  between  patients  with  PIBO  and  asthma,  in  spite  of
he  differences  in  disease  severity,  may  be  due  to  the  sample
f  assessed  children,  which  has  received  interdisciplinary
are  since  the  disease  diagnosis,  a  factor  that  may  have
ontributed  to  a  greater  control  of  the  psychosocial  factors
elated  to  the  disease.
A  multicenter  study  carried  out  in  Argentina  showed  a
ignificant  difference  in  values  related  to  the  quality  of  life
n  the  school  domain  of  patients  with  confirmed  chronic  dis-
ases  when  compared  with  healthy  children,  most  of  which
ere  asthmatic.16 The  impact  of  the  disease  on  the  school
nd  health  domains  has  already  been  demonstrated  even  in
atients  with  acute  infectious  events.17 These  findings  pro-
378  Sarria  EE  et  al.
Table  2  Quality  of  life  score  by  domain.
Domain  PIBO  (n  =  34)  Control  (n  =  34)  Difference  (95%  CI)  p-Value
Health,  mean  ±  SD 72.36  ±  15.65  81.06  ±  16.48  −8.7  (−16.6  to  −0.7)  0.031a
Emotional,  mean  ±  SD  61.25  ±  22.10  68.52  ±  20.72  −7.2  (−17.8  to  3.2)  0.172
Social, mean  ±  SD  80.46  ±  19.52  87.79  ±  17.32  −7.3  (−16.4  to  1.7)  0.113
School, mean  ±  SD  62.34  ±  20.27  72.94  ±  21.32  −10.5  (−20.8  to  −0.35)  0.043a
Psychosocial,  mean  ±  SD  70.85  ±  17.24  78.12  ±  16.27  −7.2  (−15.5  to  0.99)  0.083
Total score,  mean  ±  SD  69.53  ±  14.99  78.02  ±  14.87  −8.4  (−15.8  to  −1.14)  0.024a











































Student’s t-test for independent samples.
a p < 0.05.
ote  the  importance  of  the  subjective  viewpoint  of  these
atients  in  different  health  domains  in  relation  to  disease
mpact.  The  ongoing  study  of  HRQoL  allows  professionals
rom  different  areas  to  identify  when  it  is  necessary  to  inter-
ene  more  specifically  in  these  aspects  of  clinical  practice.
The  minimum  significant  difference  for  PedsQL  in  chil-
ren  with  health  conditions  is  of  four  points  for  each
omain.18 The  cutoff  points  for  healthy  patients  with  lower,
oderate,  and  higher  impairment  have  also  been  estab-
ished.  When  analyzing  the  present  results  with  the  cutoff
oints  described,  it  can  be  inferred  that  in  the  studied
ample,  the  HRQoL  impairment  was  moderate  and  that  the
ifference  between  the  means  of  the  groups  was  clinically
ignificant.
This  study  has  some  limitations;  first,  the  cross-sectional
esign  of  the  study  does  not  allow  conclusions  to  be  drawn
egarding  a  causal  association  between  BO  and  lower  quality
f  life  scores.  Another  limitation  is  that  the  assessed  sample
as  chosen  by  convenience.  Considering  PIBO  as  a  rare  and
hronic  disease,  the  results  appear  to  meet  the  hypothesis
f  the  present  study.  These  data  allow  a  first  diagnosis  of
RQoL  in  patients  with  PIBO.  Differences  in  quality  of  life
etween  individuals  with  PIBO  and  their  healthy  peers  could
e  attributed  to  the  disease  impairment,  since  the  other
haracteristics  of  the  control  group  were  paired.
Finally,  due  to  the  similarities  between  PIBO  and  severe
sthma  regarding  symptoms  and  functional  and  imaging
ests,  the  possibility  that  some  patients  may  have  both  dis-
ases  cannot  be  completely  discarded,  despite  fact  that  the
hronic  respiratory  clinical  picture  was  observed  after  the
cute  episode  of  PIBO.
The  authors  conclude  that  patients  with  PIBO  have  lower
RQoL  scores  than  healthy  individuals  in  the  total  score  and
n  the  health  and  school  domains.  The  present  study  rein-
orces  the  importance  of  the  inclusion  of  a  more  subjective
nd  multidimensional  tool  in  the  assessment  of  patients  with
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